Catherine P. Cheney, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vitamin D | 1 | 2018 | 3301 | 0.230 |
Why?
|
| Cholagogues and Choleretics | 1 | 1998 | 39 | 0.150 |
Why?
|
| Ursodeoxycholic Acid | 1 | 1998 | 81 | 0.150 |
Why?
|
| Viral Hepatitis Vaccines | 1 | 1997 | 72 | 0.140 |
Why?
|
| Cholangitis, Sclerosing | 1 | 1998 | 177 | 0.130 |
Why?
|
| Hepatitis C | 3 | 2002 | 1580 | 0.130 |
Why?
|
| Hepacivirus | 1 | 2000 | 1330 | 0.110 |
Why?
|
| Neoplasms | 1 | 2018 | 22131 | 0.080 |
Why?
|
| Antiviral Agents | 1 | 2000 | 3037 | 0.070 |
Why?
|
| Risk | 1 | 2018 | 9603 | 0.060 |
Why?
|
| Proportional Hazards Models | 1 | 2018 | 12448 | 0.050 |
Why?
|
| Hepatitis C Antibodies | 1 | 2000 | 147 | 0.040 |
Why?
|
| Antigens, CD1 | 1 | 2002 | 439 | 0.040 |
Why?
|
| Lectins, C-Type | 1 | 2002 | 584 | 0.040 |
Why?
|
| Flaviviridae | 1 | 1997 | 9 | 0.040 |
Why?
|
| Hepatitis Viruses | 1 | 1997 | 15 | 0.040 |
Why?
|
| Hepatitis D | 1 | 1997 | 23 | 0.040 |
Why?
|
| Th1 Cells | 1 | 2002 | 1027 | 0.030 |
Why?
|
| Vaccines, Combined | 1 | 1997 | 70 | 0.030 |
Why?
|
| Hepatitis, Viral, Human | 1 | 1997 | 141 | 0.030 |
Why?
|
| Hepatitis A | 1 | 1997 | 128 | 0.030 |
Why?
|
| Hepatitis E | 1 | 1997 | 76 | 0.030 |
Why?
|
| Hepatitis B Vaccines | 1 | 1997 | 177 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2018 | 54364 | 0.030 |
Why?
|
| Treatment Failure | 1 | 1998 | 2635 | 0.020 |
Why?
|
| Hepatitis B | 1 | 1997 | 704 | 0.020 |
Why?
|
| United States Food and Drug Administration | 1 | 1997 | 1661 | 0.020 |
Why?
|
| Aged | 1 | 2018 | 169092 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2000 | 12966 | 0.020 |
Why?
|
| Vaccination | 1 | 1997 | 3370 | 0.010 |
Why?
|
| Middle Aged | 1 | 2018 | 220603 | 0.010 |
Why?
|
| Adult | 1 | 2018 | 220995 | 0.010 |
Why?
|
| Prevalence | 1 | 2000 | 15702 | 0.010 |
Why?
|
| Humans | 5 | 2018 | 760740 | 0.010 |
Why?
|
| NK Cell Lectin-Like Receptor Subfamily B | 1 | 2002 | 84 | 0.010 |
Why?
|
| Cytotoxicity Tests, Immunologic | 1 | 2002 | 317 | 0.010 |
Why?
|
| Antigens, CD1d | 1 | 2002 | 228 | 0.010 |
Why?
|
| Male | 1 | 2018 | 360402 | 0.010 |
Why?
|
| Female | 1 | 2018 | 392203 | 0.010 |
Why?
|
| Antigens, Surface | 1 | 2002 | 1606 | 0.010 |
Why?
|
| Immunophenotyping | 1 | 2002 | 1864 | 0.010 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2002 | 1797 | 0.010 |
Why?
|
| Interferon-gamma | 1 | 2002 | 3145 | 0.010 |
Why?
|
| Killer Cells, Natural | 1 | 2002 | 2191 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 2002 | 5463 | 0.010 |
Why?
|
| United States | 1 | 1997 | 72292 | 0.000 |
Why?
|
| Cell Line | 1 | 2002 | 15577 | 0.000 |
Why?
|
| Cytokines | 1 | 2002 | 7373 | 0.000 |
Why?
|
| Liver | 1 | 2002 | 7512 | 0.000 |
Why?
|